MAGNETIC-RESONANCE SPECTROSCOPY - A POWERFUL TOOL FOR DRUG-METABOLISM STUDIES

被引:40
作者
MALETMARTINO, MC [1 ]
MARTINO, R [1 ]
机构
[1] UNIV TOULOUSE 3,F-31062 TOULOUSE,FRANCE
关键词
MAGNETIC RESONANCE SPECTROSCOPY (H-1; H-2; LI-7; C-13; F-19; P-31; SE-77); DRUG METABOLISM; ANTICANCER FLUOROPYRIMIDINES; IFOSFAMIDE; 5-FLUOROURACIL CARDIOTOXICITY; BIOLOGICAL FLUIDS; INVIVO NMR;
D O I
10.1016/0300-9084(92)90061-I
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Studies on the metabolism and disposition of drugs using nuclear magnetic resonance spectroscopy (MRS) as the analytical technique are reviewed. An overview of the main studies classed in terms of the observed magnetic nucleus (H-1, H-2, Li-7, C-13, F-19, P-31, Se-77) is followed by some typical examples of the way in which F-19 and P-31 MRS can be profitably employed to gain more understanding about the metabolism and disposition of the anticancer fluoropyrimidines (5-fluorouracil (FU) and its prodrugs) and ifosfamide (IF). The results of three recent studies carried out in our laboratory are developed. They concern the direct quantitative monitoring of the hepatic metabolism of FU in the isolated perfused mouse liver, the elucidation of the origin of the cardiotoxicity of FU and the metabolism of IF from an analysis of biofluids of patients. Finally, the advantages and limitations of MRS for investigations on drug metabolism are discussed.
引用
收藏
页码:785 / 800
页数:16
相关论文
共 103 条
[21]   F-19 NUCLEAR-MAGNETIC-RESONANCE STUDY OF FLUOROPYRIMIDINE METABOLISM IN STRAINS OF CANDIDA-GLABRATA WITH SPECIFIC DEFECTS IN PYRIMIDINE METABOLISM [J].
FASOLI, MOF ;
KERRIDGE, D ;
MORRIS, PG ;
TOROSANTUCCI, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :1996-2006
[22]  
FISCHER H, 1989, SELENIUM BIOL MED, P163
[23]   COMPARISON OF 5-FLUOROURACIL PHARMACOKINETICS FOLLOWING INTRAPERITONEAL AND INTRAVENOUS ADMINISTRATION USING INVIVO F-19 MAGNETIC-RESONANCE SPECTROSCOPY [J].
GLAHOLM, J ;
LEACH, MO ;
COLLINS, D ;
ALJEHAZI, B ;
SHARP, JC ;
SMITH, TAD ;
ADACH, J ;
HIND, A ;
MCCREADY, VR ;
WHITE, H .
BRITISH JOURNAL OF RADIOLOGY, 1990, 63 (751) :547-553
[24]   INVIVO F-19-NMR OF 5-FLUOROURACIL INCORPORATION INTO RNA AND METABOLITES IN ESCHERICHIA-COLI-CELLS [J].
GOCHIN, M ;
JAMES, TL ;
SHAFER, RH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 804 (01) :118-124
[25]   5-FLUOROURACIL CARDIOTOXICITY - A CRITICAL-REVIEW [J].
GRADISHAR, WJ ;
VOKES, EE .
ANNALS OF ONCOLOGY, 1990, 1 (06) :409-414
[26]  
GUERQUIN-KERN JL, 1991, CANCER RES, V51, P5770
[27]   MEASUREMENT OF TISSUE LITHIUM CONCENTRATION BY LITHIUM MAGNETIC-RESONANCE SPECTROSCOPY IN PATIENTS WITH BIPOLAR DISORDER [J].
GYULAI, L ;
WICKLUND, SW ;
GREENSTEIN, R ;
BAUER, MS ;
CICCIONE, P ;
WHYBROW, PC ;
ZIMMERMAN, J ;
KOVACHICH, G ;
ALVES, W .
BIOLOGICAL PSYCHIATRY, 1991, 29 (12) :1161-1170
[28]   A NEW METHOD FOR THE EVALUATION OF THE LIVER-INJURY BY F-19 MRS OF 5-FLUOROURACIL [J].
HARADA, M ;
KOGA, K ;
MIURA, I ;
NISHITANI, H .
MAGNETIC RESONANCE IN MEDICINE, 1991, 22 (02) :499-504
[29]   STUDY OF BIODISTRIBUTION OF ENFLURANE IN RATS WITH INVIVO F-19-MRI [J].
HASHIMOTO, T ;
IKEHIRA, H ;
FUKUDA, H ;
UESHIMA, Y ;
TATENO, Y .
MAGNETIC RESONANCE IMAGING, 1991, 9 (04) :577-581
[30]  
HOHENBERGER P, 1990, CHIRURGISCHES FORUM, P283